Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1574, 2007-01, pp. : 9-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Alemtuzumab: an effective front-line option for CLL?
Inpharma, Vol. 1, Iss. 1548, 2006-01 ,pp. :
Access to resources
Recommend
Fludarabine superior to chlorambucil in CLL
Inpharma, Vol. 1, Iss. 1269, 2001-01 ,pp. :
Tretinoin plus arsenic trioxide: front-line therapy for APL
Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. :
Alemtuzumab: SC and IV administration in B-CLL
Inpharma, Vol. 1, Iss. 1454, 2004-01 ,pp. :
Alemtuzumab: a costly alternative in CLL?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. :